April 22, 2015
Renowned UC San Francisco pioneers in cancer, biochemistry, medical genetics and pharmaceutical sciences have been elected as members of the American Academy of Arts and Sciences, which recognizes the world’s most accomplished leaders in science, humanities, arts, business and public affairs.
April 20, 2015
Previous HDFCCC director and long-time RAS researcher Frank McCormick will join a group of prominent cancer research and treatment institutions in a new Stand Up To Cancer (SU2C)-American Cancer Society $20 million Dream Team to combat lung cancer.
April 16, 2015
Angiogenesis inhibitors—a widely used class of cancer drugs designed to shrink tumors by preventing them from forming new blood vessels—often work in the short term, but usually become ineffective within months.
April 14, 2015
Gov. Jerry Brown is launching a statewide initiative with the University of California, to advance the field of precision medicine. The effort will involve collaborating with other academic and industry partners and starting to build the infrastructure and assemble the resources necessary to further develop the field.
April 2, 2015
Capitalizing on a rare opportunity to thoroughly analyze a tumor from a lung cancer patient who had developed resistance to targeted drug treatment, UC San Francisco scientists identified a biological escape hatch that explains the resistance, and developed a strategy in mice for shutting it down.
April 1, 2015
In closing the 2015 UCSF Helen Diller Family Comprehensive Cancer Center Symposium, President Alan Ashworth, PhD, FRS, counted himself among those who might once have underappreciated the full potential of cancer immunotherapy.
“But,” he declared, “it is clearly a field whose day has come.”
March 25, 2015
A research team at UC San Francisco has won a five-year award of $14.1 million from the Patient-Centered Outcomes Research Institute (PCORI) to investigate whether a personalized approach to breast cancer screening is as safe and effective as annual mammograms.
March 24, 2015
UC San Francisco chancellors emeriti J. Michael Bishop, MD, and Susan Desmond-Hellmann, MD, MPH, will appear next week in a Ken Burns-produced PBS documentary called “Cancer: The Emperor of All Maladies,” which is based on the Pulitzer Prize-winning book of the same name by Columbia University oncologist Siddhartha Mukherjee, MD, PhD.
March 9, 2015
A new study of acute lymphoblastic leukemia (ALL), a blood cancer that primarily affects young children, has revealed that the disease has two distinct subtypes, and provides preliminary evidence that about 13 percent of ALL cases may be successfully treated with targeted drugs that have proved highly effective in the treatment of lymphomas in adults.
March 2, 2015
Tumor recurrence following a period of remission is the main cause of death in cancer. The ability of cancer cells to remain dormant during and following therapy, only to be reactivated at a later time, frequently with greater aggressiveness, is one of the least-understood aspects of the disease.